Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Rituximab for Anti-Glomerular Basement Membrane Disease.

Jain R, Dgheim H, Bomback AS.

Kidney Int Rep. 2018 Dec 17;4(4):614-618. doi: 10.1016/j.ekir.2018.12.002. eCollection 2019 Apr. No abstract available.

2.

The spectrum of kidney biopsy findings in patients with morbid obesity.

Choung HG, Bomback AS, Stokes MB, Santoriello D, Campenot ES, Batal I, Markowitz GS, D'Agati VD.

Kidney Int. 2019 Mar;95(3):647-654. doi: 10.1016/j.kint.2018.11.026. Epub 2019 Jan 31.

PMID:
30712921
3.

Diagnostic Utility of Exome Sequencing for Kidney Disease.

Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, Li Y, Zhang J, Nestor J, Krithivasan P, Lam WY, Mitrotti A, Piva S, Kil BH, Chatterjee D, Reingold R, Bradbury D, DiVecchia M, Snyder H, Mu X, Mehl K, Balderes O, Fasel DA, Weng C, Radhakrishnan J, Canetta P, Appel GB, Bomback AS, Ahn W, Uy NS, Alam S, Cohen DJ, Crew RJ, Dube GK, Rao MK, Kamalakaran S, Copeland B, Ren Z, Bridgers J, Malone CD, Mebane CM, Dagaonkar N, Fellström BC, Haefliger C, Mohan S, Sanna-Cherchi S, Kiryluk K, Fleckner J, March R, Platt A, Goldstein DB, Gharavi AG.

N Engl J Med. 2019 Jan 10;380(2):142-151. doi: 10.1056/NEJMoa1806891. Epub 2018 Dec 26.

4.

Shortening the Duration of Corticosteroid Exposure in Minimal Change Disease: Can We Treat Adults Like Children?

Bomback AS.

Am J Nephrol. 2019;49(1):52-53. doi: 10.1159/000495351. Epub 2018 Dec 17. No abstract available.

5.

Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study.

Selewski DT, Ambruzs JM, Appel GB, Bomback AS, Matar RB, Cai Y, Cattran DC, Chishti AS, D'Agati VD, D'Alessandri-Silva CJ, Gbadegesin RA, Hogan JJ, Iragorri S, Jennette JC, Julian BA, Khalid M, Lafayette RA, Liapis H, Lugani F, Mansfield SA, Mason S, Nachman PH, Nast CC, Nester CM, Noone DG, Novak J, O'Shaughnessy MM, Reich HN, Rheault MN, Rizk DV, Saha MK, Sanghani NS, Sperati CJ, Sreedharan R, Srivastava T, Swiatecka-Urban A, Twombley K, Vasylyeva TL, Weaver DJ, Yin H, Zee J, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson BM, Smoyer WE, Flessner M, Guay-Woodford LM, Kiryluk K; CureGN Consortium.

Kidney Int Rep. 2018 Aug 3;3(6):1373-1384. doi: 10.1016/j.ekir.2018.07.021. eCollection 2018 Nov.

6.

CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.

Mariani LH, Bomback AS, Canetta PA, Flessner MF, Helmuth M, Hladunewich MA, Hogan JJ, Kiryluk K, Nachman PH, Nast CC, Rheault MN, Rizk DV, Trachtman H, Wenderfer SE, Bowers C, Hill-Callahan P, Marasa M, Poulton CJ, Revell A, Vento S, Barisoni L, Cattran D, D'Agati V, Jennette JC, Klein JB, Laurin LP, Twombley K, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson B, Smoyer WE, Guay-Woodford LM; CureGN Consortium.

Am J Kidney Dis. 2019 Feb;73(2):218-229. doi: 10.1053/j.ajkd.2018.07.020. Epub 2018 Nov 9.

PMID:
30420158
7.

Kidney Transplantation in C3 Glomerulopathy: A Case Series.

Regunathan-Shenk R, Avasare RS, Ahn W, Canetta PA, Cohen DJ, Appel GB, Bomback AS.

Am J Kidney Dis. 2019 Mar;73(3):316-323. doi: 10.1053/j.ajkd.2018.09.002. Epub 2018 Nov 7.

PMID:
30413277
8.

An Update on Therapies for Proliferative Lupus Nephritis: How Certain Can We Be About the Evidence?

Bomback AS.

Am J Kidney Dis. 2018 Nov;72(5):758-760. doi: 10.1053/j.ajkd.2018.07.007. Review. No abstract available.

PMID:
30343733
9.

Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.

Santoriello D, Husain SA, De Serres SA, Bomback AS, Crew RJ, Vasilescu ER, Serban G, Campenot ES, Kiryluk K, Mohan S, Hawkins GA, Hicks PJ, Cohen DJ, Radhakrishnan J, Stokes MB, Markowitz GS, Freedman BI, D'Agati VD, Batal I.

Kidney Int. 2018 Dec;94(6):1189-1198. doi: 10.1016/j.kint.2018.06.024. Epub 2018 Oct 2.

PMID:
30287079
10.

A Three-Headed Approach to Kidney Involvement in Rheumatic Diseases.

Bomback AS, Sise ME.

Rheum Dis Clin North Am. 2018 Nov;44(4):xiii-xiv. doi: 10.1016/j.rdc.2018.08.001. No abstract available.

PMID:
30274633
11.

Nonproliferative Forms of Lupus Nephritis: An Overview.

Bomback AS.

Rheum Dis Clin North Am. 2018 Nov;44(4):561-569. doi: 10.1016/j.rdc.2018.06.003. Epub 2018 Sep 7. Review.

PMID:
30274623
12.

Future Direction for Using Artificial Intelligence to Predict and Manage Hypertension.

Krittanawong C, Bomback AS, Baber U, Bangalore S, Messerli FH, Wilson Tang WH.

Curr Hypertens Rep. 2018 Jul 6;20(9):75. doi: 10.1007/s11906-018-0875-x. Review.

PMID:
29980865
13.

Membranous Nephropathy in a Patient With Common Variable Immune Deficiency.

Kil BH, Zachariah T, Husain SA, Nestor J, Regunathan-Shenk R, Markowitz GS, Bomback AS.

Kidney Int Rep. 2017 Dec 8;3(3):738-742. doi: 10.1016/j.ekir.2017.12.002. eCollection 2018 May. No abstract available.

14.

Membranous Nephropathy: Approaches to Treatment.

Bomback AS, Fervenza FC.

Am J Nephrol. 2018;47 Suppl 1:30-42. doi: 10.1159/000481635. Epub 2018 May 31.

15.

Management of Membranous Nephropathy in the PLA2R Era.

Bomback AS.

Clin J Am Soc Nephrol. 2018 May 7;13(5):784-786. doi: 10.2215/CJN.12461117. Epub 2018 Jan 29. No abstract available.

16.

Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series.

Avasare RS, Canetta PA, Bomback AS, Marasa M, Caliskan Y, Ozluk Y, Li Y, Gharavi AG, Appel GB.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):406-413. doi: 10.2215/CJN.09080817. Epub 2018 Jan 11.

17.

C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.

Bomback AS, Santoriello D, Avasare RS, Regunathan-Shenk R, Canetta PA, Ahn W, Radhakrishnan J, Marasa M, Rosenstiel PE, Herlitz LC, Markowitz GS, D'Agati VD, Appel GB.

Kidney Int. 2018 Apr;93(4):977-985. doi: 10.1016/j.kint.2017.10.022. Epub 2018 Jan 6.

PMID:
29310824
18.

Precision Medicine for Acute Kidney Injury (AKI): Redefining AKI by Agnostic Kidney Tissue Interrogation and Genetics.

Kiryluk K, Bomback AS, Cheng YL, Xu K, Camara PG, Rabadan R, Sims PA, Barasch J.

Semin Nephrol. 2018 Jan;38(1):40-51. doi: 10.1016/j.semnephrol.2017.09.006. Review.

19.

Whole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study.

Lata S, Marasa M, Li Y, Fasel DA, Groopman E, Jobanputra V, Rasouly H, Mitrotti A, Westland R, Verbitsky M, Nestor J, Slater LM, D'Agati V, Zaniew M, Materna-Kiryluk A, Lugani F, Caridi G, Rampoldi L, Mattoo A, Newton CA, Rao MK, Radhakrishnan J, Ahn W, Canetta PA, Bomback AS, Appel GB, Antignac C, Markowitz GS, Garcia CK, Kiryluk K, Sanna-Cherchi S, Gharavi AG.

Ann Intern Med. 2018 Jan 16;168(2):100-109. doi: 10.7326/M17-1319. Epub 2017 Dec 5. Erratum in: Ann Intern Med. 2018 Feb 20;168(4):308.

20.

Aldosterone breakthrough does not alter central hemodynamics.

Beenken A, Bomback AS.

J Renin Angiotensin Aldosterone Syst. 2017 Oct-Dec;18(4):1470320317735002. doi: 10.1177/1470320317735002.

21.

After 4 Decades of Lupus Nephritis Trials, Is There a "Best" Therapy?

Bomback AS.

Am J Kidney Dis. 2017 Sep;70(3):309-310. doi: 10.1053/j.ajkd.2017.05.016. No abstract available.

22.

A Pregnant Woman with Lupus and Nephrotic-Range Proteinuria.

Bomback AS.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1534-1537. doi: 10.2215/CJN.13251216. Epub 2017 Apr 4. No abstract available.

23.

An Elderly Man with Fatigue, Dyspnea, and Kidney Failure.

Bomback AS.

Clin J Am Soc Nephrol. 2017 May 8;12(5):836-838. doi: 10.2215/CJN.13311216. Epub 2017 Mar 8. No abstract available.

24.

Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents.

Avasare RS, Rosenstiel PE, Zaky ZS, Tsapepas DS, Appel GB, Markowitz GS, Bomback AS, Canetta PA.

Am J Nephrol. 2017;45(2):99-106. doi: 10.1159/000453081. Epub 2017 Jan 6.

25.

Complement-Mediated Glomerular Diseases: A Tale of 3 Pathways.

Bomback AS, Markowitz GS, Appel GB.

Kidney Int Rep. 2016 Jul 1;1(3):148-155. doi: 10.1016/j.ekir.2016.06.005. eCollection 2016 Sep. Review.

26.

Phosphate enemas and GFR decline: it's premature to sound the alarm.

Markowitz GS, Bomback AS, Perazella MA.

Kidney Int. 2016 Jul;90(1):13-5. doi: 10.1016/j.kint.2016.05.006.

PMID:
27312439
27.

Lupus Podocytopathy: A Distinct Entity.

Bomback AS, Markowitz GS.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):547-8. doi: 10.2215/CJN.01880216. Epub 2016 Mar 16. No abstract available.

28.

American Society of Nephrology Quiz and Questionnaire 2015: Glomerular Diseases.

Bomback AS, Perazella MA, Choi MJ.

Clin J Am Soc Nephrol. 2016 May 6;11(5):884-90. doi: 10.2215/CJN.12871215. Epub 2016 Feb 4. Erratum in: Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1513.

29.

Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety.

Bomback AS.

Blood Purif. 2016;41(1-3):166-70. doi: 10.1159/000441262. Epub 2016 Jan 15. Review.

30.

Predictors of outcome for severe IgA Nephropathy in a multi-ethnic U.S. cohort.

Arroyo AH, Bomback AS, Butler B, Radhakrishnan J, Herlitz L, Stokes MB, D'Agati V, Markowitz GS, Appel GB, Canetta PA.

Clin Nephrol. 2015 Sep;84(3):145-55. doi: 10.5414/CN108556.

PMID:
26226949
31.

Drug-induced glomerular disease: direct cellular injury.

Markowitz GS, Bomback AS, Perazella MA.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1291-9. doi: 10.2215/CJN.00860115. Epub 2015 Apr 10. Review.

32.

Aldosterone blockade in CKD: emphasis on pharmacology.

Schwenk MH, Hirsch JS, Bomback AS.

Adv Chronic Kidney Dis. 2015 Mar;22(2):123-32. doi: 10.1053/j.ackd.2014.08.003. Review.

PMID:
25704349
33.

American Society of Nephrology quiz and questionnaire 2014: glomerular diseases.

Bomback AS, Perazella MA, Choi MJ.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):716-22. doi: 10.2215/CJN.11821214. Epub 2015 Feb 9.

34.

Eculizumab in the treatment of membranoproliferative glomerulonephritis.

Bomback AS.

Nephron Clin Pract. 2014;128(3-4):270-6. doi: 10.1159/000368592. Epub 2014 Nov 11. Review.

35.

Aldosterone blockade in chronic kidney disease.

Hirsch JS, Drexler Y, Bomback AS.

Semin Nephrol. 2014 May;34(3):307-22. doi: 10.1016/j.semnephrol.2014.04.006. Epub 2014 Apr 18. Review.

PMID:
25016401
36.

Rituximab treatment for fibrillary glomerulonephritis.

Hogan J, Restivo M, Canetta PA, Herlitz LC, Radhakrishnan J, Appel GB, Bomback AS.

Nephrol Dial Transplant. 2014 Oct;29(10):1925-31. doi: 10.1093/ndt/gfu189. Epub 2014 May 27.

PMID:
24867652
37.

IgA nephropathy with minimal change disease.

Herlitz LC, Bomback AS, Stokes MB, Radhakrishnan J, D'Agati VD, Markowitz GS.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1033-9. doi: 10.2215/CJN.11951113. Epub 2014 Apr 10.

38.

Evaluation of the Scored Questionnaire to Identify Individuals with Chronic Kidney Disease in a Community-based Screening Program in Rural North Carolina.

Harward DH, Bang H, Hu Y, Bomback AS, Kshirsagar AV.

J Community Med Health Educ. 2014 Apr;4(Suppl 2):007. doi: 10.4172/2161-0711.S2-007. Epub 2014 Mar 28.

39.

Use of bortezomib in heavy-chain deposition disease: a report of 3 cases.

Patel K, Dillon JJ, Leung N, Bomback AS, Appel GB, D'Agati V, Canetta PA.

Am J Kidney Dis. 2014 Jul;64(1):123-7. doi: 10.1053/j.ajkd.2014.01.425. Epub 2014 Mar 5.

PMID:
24613055
40.

Anti-complement therapy for glomerular diseases.

Bomback AS.

Adv Chronic Kidney Dis. 2014 Mar;21(2):152-8. doi: 10.1053/j.ackd.2013.12.001. Review.

PMID:
24602464
41.

The evolution of treating glomerular diseases: letting science lead the way.

Bomback AS, Radhakrishnan J.

Adv Chronic Kidney Dis. 2014 Mar;21(2):119-20. doi: 10.1053/j.ackd.2014.01.011. No abstract available.

PMID:
24602461
42.

Sodium phosphate does not increase risk for acute kidney injury after routine colonoscopy, compared with polyethylene glycol.

Layton JB, Klemmer PJ, Christiansen CF, Bomback AS, Baron JA, Sandler RS, Kshirsagar AV.

Clin Gastroenterol Hepatol. 2014 Sep;12(9):1514-21.e3. doi: 10.1016/j.cgh.2014.01.034. Epub 2014 Jan 29.

43.

Lupus nephritis: Ancestry, genetic risk and health disparities.

Bomback AS, Gharavi AG.

Nat Rev Nephrol. 2013 Dec;9(12):699-700. doi: 10.1038/nrneph.2013.210. Epub 2013 Oct 15.

PMID:
24126589
44.

Oral paricalcitol as antiproteinuric agent in chronic kidney disease.

de Lorenzo A, Salanova L, Bomback AS, Moya M, Coronel F, Bernis C, Sánchez-Tomero JA, Álvarez V.

Nefrologia. 2013;33(5):709-15. doi: 10.3265/Nefrologia.pre2013.Jun.11928.

45.

Toward a working definition of C3 glomerulopathy by immunofluorescence.

Hou J, Markowitz GS, Bomback AS, Appel GB, Herlitz LC, Barry Stokes M, D'Agati VD.

Kidney Int. 2014 Feb;85(2):450-6. doi: 10.1038/ki.2013.340. Epub 2013 Sep 25.

46.

Urinary eosinophils in AIN: farewell to an old biomarker?

Perazella MA, Bomback AS.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1841-3. doi: 10.2215/CJN.08620813. Epub 2013 Sep 19. No abstract available.

47.

Definition, identification and treatment of resistant hypertension in chronic kidney disease patients.

Drexler YR, Bomback AS.

Nephrol Dial Transplant. 2014 Jul;29(7):1327-35. doi: 10.1093/ndt/gft346. Epub 2013 Sep 17. Review.

PMID:
24046194
48.

Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.

Hogan J, Bomback AS, Mehta K, Canetta PA, Rao MK, Appel GB, Radhakrishnan J, Lafayette RA.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2072-81. doi: 10.2215/CJN.02840313. Epub 2013 Sep 5.

49.

The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program.

Memon I, Norris KC, Bomback AS, Peralta C, Li S, Chen SC, McCullough PA, Whaley-Connell A, Jurkovitz C, Tamura MK, Saab G; for the Kidney Early Evaluation Program Investigators.

Cardiorenal Med. 2013 Jul;3(2):120-127. Epub 2013 Jun 1.

50.

The modern spectrum of renal biopsy findings in patients with diabetes.

Sharma SG, Bomback AS, Radhakrishnan J, Herlitz LC, Stokes MB, Markowitz GS, D'Agati VD.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1718-24. doi: 10.2215/CJN.02510213. Epub 2013 Jul 25.

Supplemental Content

Loading ...
Support Center